Skip to main content

Table 5 Three-year Excess Hazard Ratios (EHR) and 95% confidence intervals (95%CI) according to implementation of standardised cancer patient pathways (CPP) in Denmark

From: Prognostic consequences of implementing cancer patient pathways in Denmark: a comparative cohort study of symptomatic cancer patients in primary care

 

Before CPP

During CPP

After CPP

    

Total

CPP referred

EHR

(95%CI)

EHR

(95%CI)

EHR

(95%CI)

EHR

(95%CI)

CRC

1.16

(0.87;1.57)

1.11

(0.91;1.36)

1

ref

1.13

(0.81;1.57)

Lung

1.30

(1.09;1.55)

1.13

(0.99;1.28)

1

ref

0.77

(0.62;0.95)

Melanoma

1.11

(0.48;2.55)

0.64

(0.31;1.32)

1

ref

1.97

(0.65;5.97)

Head & Neck

2.12

(1.26;3.56)

1.25

(0.79;1.97)

1

ref

1.36

(0.62;2.98)

Upper GI

1.15

(0.92;1.43)

0.93

(0.79;1.10)

1

ref

1.00

(0.74;1.34)

Gynaecological

1.99

(1.29;3.07)

1.15

(0.81;1.65)

1

ref

0.81

(0.40;1.62)

Urinary system

1.49

(0.98;2.26)

0.93

(0.68;1.27)

1

ref

0.67

(0.40;1.12)

Total

1.35

(1.21;1.51)

1.06

(0.98;1.15)

1

ref

0.91

(0.79;1.04)

  1. Last column shows EHRs and 95%CIs between referral route (CPP or not) in 2010
  2. EHRs adjusted for sex, age, tumour stage, comorbidity (Charlson’s Comorbidity Index), educational level, disposable income, diagnosis (total only) and ovarian cancer (gynaecological cancers only). Estimates in bold indicate a statistical significance of p < 0.05 or less
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us